Related Experiment Video
Updated: Jun 25, 2026
07:20
Delivery of Cardioactive Therapeutics in a Porcine Myocardial Infarction Model
Published on: February 10, 2023
Cardioprotection requires taking out the trash
Roberta A Gottlieb1, Kim D Finley, Robert M Mentzer
1The BioScience Center, San Diego State University, San Diego, CA 92182-4650, USA. robbieg@sciences.sdsu.edu
Basic Research in Cardiology
|February 27, 2009
Summary
Autophagy, a cellular process, protects the heart from damage. This review explores how autophagy and preconditioning work together to enhance cardiac tolerance to ischemia and reperfusion injury.
Area of Science:
- Cellular Biology
- Cardiovascular Science
- Molecular Medicine
Background:
- Autophagy is a vital cellular process for removing damaged components and recycling proteins, crucial during starvation.
- In the heart, autophagy is activated by various stressors including hypoxia, exercise, and ischemic preconditioning.
- Upregulation of autophagy correlates with protection against ischemia/reperfusion injury, while its inhibition diminishes cardioprotection.
Purpose of the Study:
- To review the known mechanisms linking preconditioning and autophagy in the heart.
- To elucidate how these pathways converge to protect the heart from ischemic damage.
Main Methods:
- Literature review of studies on autophagy, preconditioning, and cardiac protection.
- Analysis of signaling pathways involved in preconditioning and their potential interaction with autophagy.
Main Results:
- Autophagy upregulation is linked to enhanced cardiac tolerance to ischemia.
- Inhibition of autophagy compromises the cardioprotective effects of preconditioning.
- The precise molecular mechanisms connecting preconditioning and autophagy remain largely undefined.
Conclusions:
- Autophagy plays a significant role in mediating cardioprotection against ischemia/reperfusion injury.
- Understanding the convergence of preconditioning and autophagy pathways is critical for developing novel therapeutic strategies for heart protection.
Related Concept Videos
01:23Cardiopulmonary Resuscitation III: AED Use
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:21Cardiopulmonary Resuscitation I: Adult
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...